amelparib (JPI-289) / Jeil  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
amelparib (JPI-289) / Jeil
NCT03062397: Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke

Unknown status
2a
110
RoW
JPI-289 Low-dose, JPI-289 High-dose, Placebo
Jeil Pharmaceutical Co., Ltd.
Acute Ischemic Stroke
12/20
12/21

Download Options